RECRUITINGINTERVENTIONAL
The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease
About This Trial
This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease
Who May Be Eligible (Plain English)
Who May Qualify:
- Male or female over 20 years old, diagnosed with Parkinson's disease.
Who Should NOT Join This Trial:
- People with Parkinson's disease Dementia, or Lactose Intolerance
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Male or female over 20 years old, diagnosed with Parkinson's disease.
Exclusion Criteria:
* People with Parkinson's disease Dementia, or Lactose Intolerance
Treatments Being Tested
DRUG
Miyarisan-BM (Clostridium Butyricum Miyairi)
probiotics
Locations (1)
Kaohsiung Medical Univeristy Hospital
Kaohsiung City, Taiwan